Non interventional post-authorisation safety study (PASS) to define the incidence of and potential risk factors for procedure-related neurological adverse events (AE) in patients undergoing ultrasound guided foam sclerotherapy (UGFS) for the treatment of lower limb varicose veins (VV) using Fibrovein 3% and 1% (sodium tetradecyl sulphate, STS, injection) incorporating a drug utilisation study (Fibrovein PASS)

ENCePP Code of conduct

No

Data sources

• Data sources (types):
  Other
• Data sources (types), other:
  Prospective patient-based data collection

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No